0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......

Journal Articles

in Colorectal Cancer
 61-80 of 138 Articles
The Rational Clinical Examination | 
Alexander C. Ford, MD, MRCP; Nicholas J. Talley, MD, PhD; Sander J. O. Veldhuyzen van Zanten, MD, PhD; et al.
JAMA. 2008;300(15):1793-1805. doi:10.1001/jama.300.15.1793.
Includes: CME

Original Contribution |  FREE
Virginia G. Kaklamani, MD, DSc; Kari B. Wisinski, MD; Maureen Sadim, BS; et al.
JAMA. 2008;300(13):1523-1531. doi:10.1001/jama.300.13.1523.

Editorial | 
Hemant K. Roy, MD; Laura K. Bianchi, MD
JAMA. 2008;300(12):1459-1461. doi:10.1001/jama.300.12.1459.

Original Contribution |  FREE
David A. Lieberman, MD; Jennifer L. Holub, MPH; Matthew D. Moravec, BS; et al.
JAMA. 2008;300(12):1417-1422. doi:10.1001/jama.300.12.1417.

JAMA Patient Page |  FREE
Janet M. Torpy, MD; Cassio Lynm, MA; Richard M. Glass, MD
JAMA. 2008;300(12):1480. doi:10.1001/jama.300.12.1480.
Includes: Supplemental Content

The World in Medicine | 
Joan Stephenson, PhD
JAMA. 2008;300(11):1291. doi:10.1001/jama.300.11.1291-a.

Editorial | 
Boris Pasche, MD, PhD
JAMA. 2008;299(21):2564-2565. doi:10.1001/jama.299.21.2564.

Original Contribution |  FREE
Jennifer A. Chan, MD, MPH; Jeffrey A. Meyerhardt, MD, MPH; Donna Niedzwiecki, PhD; et al.
JAMA. 2008;299(21):2515-2523. doi:10.1001/jama.299.21.2515.

From the Centers for Disease Control and Prevention |  FREE
JAMA. 2008;299(21):2501-2502. doi:10.1001/jama.299.21.2501.

Original Contribution |  FREE
Gerardo Heiss, MD; Robert Wallace, MD; Garnet L. Anderson, PhD; et al.
JAMA. 2008;299(9):1036-1045. doi:10.1001/jama.299.9.1036.

Medical News & Perspectives | 
Mike Mitka
JAMA. 2008;299(6):622. doi:10.1001/jama.299.6.622.

Preliminary Communication |  FREE
Aaron J. Schetter, PhD, MPH; Suet Yi Leung, MD; Jane J. Sohn, PhD; et al.
JAMA. 2008;299(4):425-436. doi:10.1001/jama.299.4.425.

Editorial | 
Marko Simunovic, MD, MPH; Nancy N. Baxter, MD, PhD
JAMA. 2007;298(18):2194-2195. doi:10.1001/jama.298.18.2194.

Original Contribution |  FREE
Sandra L. Wong, MD, MS; Hong Ji, MS; Brent K. Hollenbeck, MD, MS; et al.
JAMA. 2007;298(18):2149-2154. doi:10.1001/jama.298.18.2149.

Medical News and Perspectives | 
Tracy Hampton, PhD
JAMA. 2007;298(12):1387. doi:10.1001/jama.298.12.1387.

Original Contribution |  FREE
Bernard F. Cole, PhD; John A. Baron, MD; Robert S. Sandler, MD; et al.
JAMA. 2007;297(21):2351-2359. doi:10.1001/jama.297.21.2351.

Clinical Crossroads | 
Gerald W. Smetana, MD
JAMA. 2007;297(19):2121-2130. doi:10.1001/jama.297.19.2121.
Includes: CME

Editorial | 
Arden M. Morris, MD, MPH
JAMA. 2006;296(23):2855-2856. doi:10.1001/jama.296.23.2855.

Original Contribution |  FREE
Cary P. Gross, MD; Martin S. Andersen, BA; Harlan M. Krumholz, MD, ScM; et al.
JAMA. 2006;296(23):2815-2822. doi:10.1001/jama.296.23.2815.

Preliminary Communication |  FREE
Patrick Veit-Haibach, MD; Christiane A. Kuehle, MD; Thomas Beyer, PhD; et al.
JAMA. 2006;296(21):2590-2600. doi:10.1001/jama.296.21.2590.

Sign in

Purchase Options

• Subscribe to the journal
• Rent this article ?

A free personal account provides

• Free current issues on The JAMA Network Reader
• Free quizzes on The JAMA Network Challenge
• Commenting and personalized alerts
From The JAMA Network
JAMA Oncology
Invited Commentary  | 
Biomarkers of Fluorouracil Toxicity Insight From the PETACC-8 Trial
Steven M. Offer, PhD; Robert B. Diasio, MD
JAMA Oncology
Original Investigation  | 
DPYD Genotyping to Predict Adverse Events Following Treatment With Flourouracil-Based Adjuvant Chemotherapy in Patients With Stage III Colon Cancer A Secondary Analysis of the PETACC-8 Randomized Clinical Trial
Valérie Boige, MD, PhD; Marc Vincent, PhD; Philippe Alexandre, MS; et al.
JAMA Oncology
Invited Commentary  | 
Microsatellite Instability and BRAF and KRAS Mutations in Stage III Colon Cancer Requirements for Accurate Prognosis Assessment
Dirk Klingbiel, PhD; Sabine Tejpar, MD, PhD
JAMA Oncology
Original Investigation  | 
Prognostic Effect of BRAF and KRAS Mutations in Patients With Stage III Colon Cancer Treated With Leucovorin, Fluorouracil, and Oxaliplatin With or Without Cetuximab A Post Hoc Analysis of the PETACC-8 Trial
Julien Taieb, MD, PhD; Aziz Zaanan, MD, PhD; Karine Le Malicot, MS; et al.